"Post-TIPS HE [hepatic encephalopathy] may reflect the patients' overall vulnerability leading to an increased risk for complications and thus explaining the overall poorer prognosis of these patients ...

“RFX [rifaximin] therapy is effective and well-tolerated in preventing HE and can be used as the first choice in the prophylaxis of HE after TIPSS,” the authors wrote. This study was led by Yangyang ...

Rifaximin improves the gut microenvironment by reducing the abundance of harmful bacteria while increasing probiotic bacteria. It inhibits the translocation of bacteria from the mouth to the intestine ...

Please provide your email address to receive an email when new articles are posted on . FMT demonstrated a favorable safety profile with no related adverse or serious adverse events. Hepatic ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Fewer patients treated with rifaximin had an overt ...

Roughly half as many patients with cirrhosis in remission from overt hepatic encephalopathy (OHE) experienced a breakthrough episode with rifaximin monotherapy compared with lactulose monotherapy, a ...

Hepatic encephalopathy (HE) is a condition that can affect the brain in people who have chronic liver disease. It happens when a damaged liver cannot effectively filter ammonia and other toxins out of ...

Learn how beta-blockers, including carvedilol, can be used in advanced liver disease to manage portal hypertension and reduce ...

(RTTNews) - Bausch Health Companies Inc. (BHC.TO) on Friday said its Phase 3 RED-C clinical program evaluating amorphous rifaximin solid soluble dispersion (SSD) in adults with liver cirrhosis for the ...